Home › Mitral Valve Insufficiency › New Jersey › Newark
Mitral Valve Insufficiency clinical trials in Newark, NJ
6 studies for Mitral Valve Insufficiency are looking for participants at sites in and around Newark (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
TVMR With the INNOVALVE System Trial - Early Feasibility Study
Recruiting
- Morristown Medical Center, Morristown · 17 mi away
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Recruiting
- Morristown Medical Center, Morristown · 17 mi away
ATLAS (AltaValve) Pivotal Trial
Recruiting
- AHS Hospital Corp., Morristown · 17 mi away
CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry
RecruitingObservational study
- Morristown Medical Center, Morristown · 17 mi away
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Recruiting
- St Michael/Prime Healthcare Services, Newark
Assessing the Relationship Between Symptoms and Mitral Regurgitnant. Severity
RecruitingObservational study
- Morristown Medical Center, Morristown · 17 mi away
Mitral Valve Insufficiency trials in other cities
- New York City, NY14 studies
- Los Angeles, CA9 studies
- Atlanta, GA9 studies
- Cleveland, OH8 studies
- Houston, TX8 studies
- Portland, OR8 studies
- The Bronx, NY7 studies
- Phoenix, AZ7 studies
- Nashville, TN7 studies
- Minneapolis, MN6 studies
- Boston, MA6 studies
- Thousand Oaks, CA6 studies
Other studies in Newark
- Breast Cancer18 studies
- Non-Small Cell Lung Cancer14 studies
- Spinal Cord Injuries13 studies
- Acute Myeloid Leukemia12 studies
- Metastatic Cancer10 studies
- Heart Failure10 studies
- Pancreatic Cancer9 studies
- Cardiovascular Disease9 studies
- Melanoma8 studies
- Lung Cancer7 studies
- Cancer (all types)7 studies
- Crohn's Disease7 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.